ICU Medical Calls Itself a “Pure-Play Infusion” Leader, Details Pricing, Pumps and Buyback Plans

ICU Medical (NASDAQ: ICUI) executives highlighted the company's evolution into what CEO Vivek Jain described as "the world's only pure-play infusion company" during a fireside chat at the 25th Annual Needham Healthcare Conference, while also addressing pricing dynamics, product roadmaps, macro pressures, and capital allocation priorities. Company evolution and investment positioning Jain said ICU Medical has